Canadian International Pharma Corp. Announces Appointment of New Director

CANADIAN INTERNATIONAL PHARMA CORP.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR

DISSEMINATION IN THE UNITED STATES

News Release No: 20-05

Trading symbol: TSX-V – NEX: CIP.H

Canadian International Pharma Corp. Announces Appointment of New Director

West Vancouver, British Columbia – September 3, 2020 – Canadian International Pharma Corp.

(the “Company”) announces that is has appointed Ron Schmitz as a director of the Company.

Mr. Schmitz is the Principal and President of ASI Accounting Services Inc., which has provided

administrative, accounting and office services to public and private companies since July, 1995. Mr.

Schmitz has served as a Director and/or Chief Fina ncial Officer of various public companies since 1997

and currently holds these positions with several public and private companies.

For further information, contact Douglas L. Mason at 604.922.2030

CANADIAN INTERNATIONAL PHARMA CORP.

“Douglas L. Mason”

Douglas L. Mason, CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the

TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.